Some individuals who have lost weight using GLP-1 medication have gained enough confidence to step into a gym environment for the first time
This personalized approach increases the chances of successful recovery
Based on a receptor-interaction model, structural modifications of the benzene and pyridine rings led to the identification of compound 26 (Figure 5), which includes a 2,4-dichlorophenyl group at two positions, as a potent (IC 50 = 0.13 M), selective (DPP-8/DPP-4 = 215, DPP-9/DPP-4 = 192), and in vivo efficacious DPP-4 inhibitor
We experiment with the model by changing the inputs or changing parameters (for example, a parameter that gives the strength of a particular allosteric interaction) and determine what the effect is
Patient-specific, not office-use
Patients will then receive the appropriate weight loss prescription based on the analysis and assessment earlier carried out by the clinician